Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 15.
doi: 10.1002/acn3.70220. Online ahead of print.

A Comprehensive Overview of the Clinical, Electrophysiological, and Neuroimaging Features of BPAN: Insights From a New Case Series

Seda Susgun  1   2 , Ozgu Kizek  3   4 , Sibel Aylin Ugur Iseri  1 , Ibrahim Kamaci  3 , Ayse Deniz Elmali  3   4 , Pinar Iscen  3 , Berfin Gulkaya Guzel  5 , Gul Yalcin Cakmakli  6 , Bulent Elibol  7 , Berril Donmez  8 , Raif Cakmur  8 , Pinar Topaloglu  3   9 ; Turkish NBIA Study Group; Nerses Bebek  3   4 , Murat Emre  3 , Zuhal Yapici  3   9
Collaborators, Affiliations
Free article

A Comprehensive Overview of the Clinical, Electrophysiological, and Neuroimaging Features of BPAN: Insights From a New Case Series

Seda Susgun et al. Ann Clin Transl Neurol. .
Free article

Abstract

Background: Neurodegeneration with brain iron accumulation (NBIA) comprises a genetically and clinically heterogeneous group of rare neurological disorders characterized particularly by iron accumulation in the basal ganglia. To date, 15 genes have been associated with NBIA. Among them, WDR45, linked to beta-propeller protein-associated neurodegeneration (BPAN), represents the only X-linked dominant subtype of NBIA. Herein, clinical, electrophysiological, and neuroimaging evaluations were used to broaden the understanding of BPAN in a newly reported case series.

Methods: This study included 10 individuals with BPAN, categorized into three age groups. WDR45 variant data retrieved from next-generation sequencing or Sanger sequencing were reviewed and reassessed. Comprehensive clinical evaluations including magnetic resonance imaging (MRI), fluorodeoxyglucose positron emission tomography (FDG-PET), and video electroencephalographic monitoring were conducted.

Results: The clinical manifestations were highly heterogeneous, with cognitive impairment being a consistent finding among the patients, with variable severity. The associated WDR45 variants are likely to exert loss-of-function effects. Electroencephalogram (EEG) abnormalities included age-dependent background slowing and epileptiform discharges. MRI indicated a characteristic pattern, while two patients lacked these typical findings. FDG-PET imaging demonstrated hypometabolism extending beyond cerebral structures, with predominant cerebellar and pontine involvement in pediatric patients and frontoparietal hypometabolism in adults.

Conclusions: This study contributes further to our understanding of the heterogeneous clinical spectrum of BPAN. Genotype-phenotype correlation in BPAN remains unclear due to the absence of sufficiently large cohorts in the literature, including the present study. Nevertheless, even within this small sample, the phenotypic heterogeneity observed among individuals harboring the same genotype highlights the biological complexity of the disease. Neuroimaging findings may reflect progressive and widespread neurological involvement in an age-dependent pattern, whereas EEG data suggest that epilepsy severity tends to decrease after adolescence.

Keywords: WDR45; beta‐propeller protein‐associated neurodegeneration (BPAN); epilepsy; fluorodeoxyglucose positron emission tomography (FDG‐PET); magnetic resonance imaging (MRI); neurodegeneration with brain iron accumulation (NBIA).

PubMed Disclaimer

References

    1. A. Gregory, M. A. Kurian, T. B. Haack, and S. J. Hayflick, “Neurodegeneration With Brain Iron Accumulation Disorders Overview,” in GeneReviews, ed. M. P. Adam, J. Feldman, G. M. Mirzaa, R. A. Pagon, S. E. Wallace, and A. Amemiya (University of Washington, 2013).
    1. V. Iankova, I. Karin, T. Klopstock, and S. A. Schneider, “Emerging Disease‐Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders,” Frontiers in Neurology 12 (2021): 629414.
    1. H. Kolarova, J. Tan, T. M. Strom, T. Meitinger, M. Wagner, and T. Klopstock, “Lifetime Risk of Autosomal Recessive Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders Calculated From Genetic Databases,” eBioMedicine 77 (2022): 103869.
    1. C. Marras, A. Lang, B. P. van de Warrenburg, et al., “Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force,” Movement Disorders 31, no. 4 (2016): 436–457.
    1. P. Seibler, L. F. Burbulla, M. Dulovic, et al., “Iron Overload Is Accompanied by Mitochondrial and Lysosomal Dysfunction in WDR45 Mutant Cells,” Brain 141, no. 10 (2018): 3052–3064.

LinkOut - more resources